Specific bronchial reactivity to toluene diisocyanate: dose-response relationship. 1986

P L Paggiaro, and L Lastrucci, and F Pardi, and O Rossi, and E Bacci, and D Talini

20 patients with toluene diisocyanate (TDI)-induced asthma were examined in order to assess their threshold of response to TDI during specific bronchial provocative tests (BPT). Specific bronchial hyperresponsiveness was evaluated by performing, on different days, specific BPT with increasing concentrations of TDI until a positive response was obtained; the threshold of response to TDI (low: 0.02-0.05 ppm; moderate: 0.1 ppm; high: 0.2-0.25 ppm) and the pattern of positive response were evaluated in comparison with some clinical features of the disease. The threshold of airway response to TDI was low in 9, moderate in 7 and high in 4 patients. No evident relationship was observed between the threshold of response to TDI and the pattern of positive response to the lower TDI concentration (immediate in 5, late in 8 and dual in 7 subjects) or other clinical features (duration of asthmatic symptoms, smoking habits, cessation of work, nonspecific bronchial hyperresponsiveness to methacholine); however, 6 out of 9 patients with low threshold had nonspecific bronchial hyperreactivity in comparison with 6 out of 11 patients with moderate or high threshold. In 10 out of 13 patients who performed two positive BPT with different TDI concentrations, the pattern of response was the same either at lower and at higher TDI concentrations; 3 subjects who had a late reaction at the lower concentration showed a dual reaction to the higher TDI concentration. A relationship between the degree of the specific bronchial reaction (% fall in FEV1 from baseline value) and TDI concentration during BPT was observed for the immediate reaction but not for the late reaction.

UI MeSH Term Description Entries
D008688 Methacholine Compounds A group of compounds that are derivatives of beta-methylacetylcholine (methacholine). Compounds, Methacholine
D001980 Bronchi The larger air passages of the lungs arising from the terminal bifurcation of the TRACHEA. They include the largest two primary bronchi which branch out into secondary bronchi, and tertiary bronchi which extend into BRONCHIOLES and PULMONARY ALVEOLI. Primary Bronchi,Primary Bronchus,Secondary Bronchi,Secondary Bronchus,Tertiary Bronchi,Tertiary Bronchus,Bronchi, Primary,Bronchi, Secondary,Bronchi, Tertiary,Bronchus,Bronchus, Primary,Bronchus, Secondary,Bronchus, Tertiary
D001985 Bronchial Provocation Tests Tests involving inhalation of allergens (nebulized or in dust form), nebulized pharmacologically active solutions (e.g., histamine, methacholine), or control solutions, followed by assessment of respiratory function. These tests are used in the diagnosis of asthma. Allergen Bronchial Provocation Tests,Allergen Challenge, Endobronchial,Antigen Bronchial Provocation Tests,Bronchial Allergen Challenge,Bronchial Challenge Tests,Inhalation Provocation Tests,Provocation Tests, Bronchial,Endobronchial Challenge Tests,Allergen Challenge, Bronchial,Allergen Challenges, Bronchial,Allergen Challenges, Endobronchial,Bronchial Allergen Challenges,Bronchial Challenge Test,Bronchial Provocation Test,Challenge Test, Bronchial,Challenge Test, Endobronchial,Challenge Tests, Bronchial,Challenge Tests, Endobronchial,Challenge, Bronchial Allergen,Challenge, Endobronchial Allergen,Challenges, Bronchial Allergen,Challenges, Endobronchial Allergen,Endobronchial Allergen Challenge,Endobronchial Allergen Challenges,Endobronchial Challenge Test,Inhalation Provocation Test,Provocation Test, Bronchial,Provocation Test, Inhalation,Provocation Tests, Inhalation,Test, Bronchial Challenge,Test, Bronchial Provocation,Test, Endobronchial Challenge,Test, Inhalation Provocation,Tests, Bronchial Challenge,Tests, Bronchial Provocation,Tests, Endobronchial Challenge,Tests, Inhalation Provocation
D003485 Cyanates Organic salts of cyanic acid containing the -OCN radical. Cyanate
D004056 Differential Threshold The smallest difference which can be discriminated between two stimuli or one which is barely above the threshold. Difference Limen,Just-Noticeable Difference,Weber-Fechner Law,Difference Limens,Difference, Just-Noticeable,Differences, Just-Noticeable,Differential Thresholds,Just Noticeable Difference,Just-Noticeable Differences,Law, Weber-Fechner,Limen, Difference,Limens, Difference,Threshold, Differential,Thresholds, Differential,Weber Fechner Law
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005541 Forced Expiratory Volume Measure of the maximum amount of air that can be expelled in a given number of seconds during a FORCED VITAL CAPACITY determination . It is usually given as FEV followed by a subscript indicating the number of seconds over which the measurement is made, although it is sometimes given as a percentage of forced vital capacity. Forced Vital Capacity, Timed,Timed Vital Capacity,Vital Capacity, Timed,FEVt,Capacities, Timed Vital,Capacity, Timed Vital,Expiratory Volume, Forced,Expiratory Volumes, Forced,Forced Expiratory Volumes,Timed Vital Capacities,Vital Capacities, Timed,Volume, Forced Expiratory,Volumes, Forced Expiratory
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001249 Asthma A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL). Asthma, Bronchial,Bronchial Asthma,Asthmas
D014051 Toluene 2,4-Diisocyanate Skin irritant and allergen used in the manufacture of polyurethane foams and other elastomers. Diisocyanatotoluene,Tolylene Diisocyanate,2,4-Toluenediisocyanate,Toluene Diisocyanate,2,4 Toluenediisocyanate,2,4-Diisocyanate, Toluene,Diisocyanate, Toluene,Diisocyanate, Tolylene,Toluene 2,4 Diisocyanate

Related Publications

P L Paggiaro, and L Lastrucci, and F Pardi, and O Rossi, and E Bacci, and D Talini
April 1986, Thorax,
P L Paggiaro, and L Lastrucci, and F Pardi, and O Rossi, and E Bacci, and D Talini
July 2014, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology,
P L Paggiaro, and L Lastrucci, and F Pardi, and O Rossi, and E Bacci, and D Talini
January 1984, La Medicina del lavoro,
P L Paggiaro, and L Lastrucci, and F Pardi, and O Rossi, and E Bacci, and D Talini
January 1991, Gigiena truda i professional'nye zabolevaniia,
P L Paggiaro, and L Lastrucci, and F Pardi, and O Rossi, and E Bacci, and D Talini
January 1979, La Medicina del lavoro,
P L Paggiaro, and L Lastrucci, and F Pardi, and O Rossi, and E Bacci, and D Talini
July 2016, Archives of toxicology,
P L Paggiaro, and L Lastrucci, and F Pardi, and O Rossi, and E Bacci, and D Talini
October 1993, Chest,
P L Paggiaro, and L Lastrucci, and F Pardi, and O Rossi, and E Bacci, and D Talini
January 2002, Report on carcinogens : carcinogen profiles,
P L Paggiaro, and L Lastrucci, and F Pardi, and O Rossi, and E Bacci, and D Talini
June 1978, Lancet (London, England),
P L Paggiaro, and L Lastrucci, and F Pardi, and O Rossi, and E Bacci, and D Talini
July 1978, Lancet (London, England),
Copied contents to your clipboard!